Clinical Trial Update: ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR Trial" [Phase 2, Phase 3]

View source ↗

Summary

The ARCHeR trial evaluating the ACCULINK carotid stent system for revascularization in high-risk patients has completed Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carotid Artery Disease
• Carotid Atherosclerosis

Drugs mentioned

• ACCULINK Carotid Stent System

Snippet

Sponsor: Abbott Medical Devices | Conditions: Carotid Atherosclerosis, Carotid Artery Disease | Phase 2, Phase 3 | Status: COMPLETED